论文部分内容阅读
早在1977年我组开始以益气活血注射液治疗肺心病急性发作期患者89例,结果对细胞免疫功能的改善与转移因子对照组效同,体液免疫功能亦有明显好转,对舌腹面静脉淤张,心电图P波振幅,甲皱微循环及眼底血管等各项指标均有显著改善。为进一步研究其对肺心病急性发作期患者血循环和肺动脉压的影响,自1990年开始,对住院的81例肺心病急性发作期患者给予益气活血注射液,并分别与硝基吡啶和对照组进行对比观察,现将结果报告如下。
As early as 1977, our group began to treat 89 cases of acute exacerbation of pulmonary heart disease with Yi Qi Huo Xue injection. The results were similar to the improvement of cellular immune function and the control group of transfer factor, and the humoral immune function also showed significant improvement. Siltation, electrocardiographic P wave amplitude, nailfold microcirculation, and fundus vessels have all improved significantly. To further study its effect on blood circulation and pulmonary arterial pressure in patients with acute exacerbation of pulmonary heart disease, since the beginning of 1990, 81 cases of hospitalized patients with acute exacerbation of pulmonary heart disease were given Qi Qi Huoxue injection, and with nitropyridine and control group For comparison observations, the results are reported below.